Treace Medical Concepts, Inc. SEC filings TMCI
Treace Medical Concepts, Inc. has 445 filings in SEC EDGAR's recent list, going back to Jan 21, 2015. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2026 | Nov 6, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 19, 2026 |
| S-8 | Employee stock plan registration | May 8, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Apr 9, 2026 | Apr 8, 2026 |
| ARS | Annual report to shareholders | Apr 6, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | Apr 3, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Change to shareholder rights, Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 16, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2025 | May 21, 2025 |
| S-8 | Employee stock plan registration | May 9, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| DEF 14A | Proxy statement | Apr 7, 2025 | Apr 7, 2025 |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2025 | Apr 7, 2025 |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 14, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2024 | May 21, 2024 |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| DEF 14A | Proxy statement | Apr 2, 2024 | Apr 2, 2024 |
| ARS | Annual report to shareholders | Apr 2, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2024 | Jan 8, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 4, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2023 | May 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 8, 2023 | — |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 424B5 | Prospectus supplement | Feb 9, 2023 | — |
| 424B5 | Prospectus supplement | Feb 7, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 7, 2023 | — |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2022 | Sep 27, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2022 | May 17, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
May 4, 2022 | Apr 29, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2022 | — |
| DEF 14A | Proxy statement | Apr 4, 2022 | May 17, 2022 |
| S-8 | Employee stock plan registration | Mar 4, 2022 | — |
| 10-K | Annual report | Mar 4, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2022 | Jan 10, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 10-Q/A | Amended quarterly report | May 28, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | May 25, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 25, 2021 | May 25, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Apr 27, 2021 | Apr 27, 2021 |
| S-8 | Employee stock plan registration | Apr 27, 2021 | — |
| 424B4 | Prospectus | Apr 26, 2021 | — |
| EFFECT | Filing | Apr 22, 2021 | — |
| S-1MEF | Filing | Apr 22, 2021 | — |
| CERT | 8a cert | Apr 22, 2021 | — |
| CORRESP | Letter to the SEC | Apr 20, 2021 | — |
| CORRESP | Letter to the SEC | Apr 20, 2021 | — |
| 8-A12B | Filing | Apr 20, 2021 | — |
| CORRESP | Letter to the SEC | Apr 19, 2021 | — |
| S-1/A | Amended registration statement | Apr 19, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| CORRESP | Letter to the SEC | Mar 30, 2021 | — |
| S-1 | Registration statement | Mar 30, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2021 | — |
| DRS | Filing | Feb 12, 2021 | — |
| D | Filing | May 10, 2017 | — |
| D | Filing | Feb 9, 2017 | — |
| D/A | Filing | Mar 9, 2015 | — |
| D/A | Filing | Feb 26, 2015 | — |
| D/A | Filing | Feb 11, 2015 | — |
| D | Filing | Jan 21, 2015 | — |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TMCI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 1630627
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.